Using health records to predict heart disease after kidney transplants
Official title: Leveraging a novel health records platform to predict the development of cardiovascular disease following kidney transplantation
Funded at Johns Hopkins University · NIH-10894626 · Data updated 2026-11-12
This study is looking to create a helpful tool that can predict the risk of heart disease in people who have had a kidney transplant, by examining their health history and other important factors, so that doctors can better care for those who might be at higher risk.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $56,974 |
| NIH project number | 5F30HL168842-02 |
| Project ID | NIH-10894626 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have received a kidney transplant and are at risk for developing cardiovascular disease.
✕Less likely to help
Patients who have not undergone kidney transplantation or those without risk factors for cardiovascular disease may not benefit from this research.
What this research studies
This research aims to develop a specific model to predict the risk of cardiovascular disease (CVD) in patients who have undergone kidney transplantation. It will utilize a novel health records platform to analyze various factors, including the effects of immunosuppressive medications, chronic kidney disease history, and socioeconomic conditions. By capturing detailed health data and biomarkers, the study seeks to create a more accurate risk assessment tool tailored for kidney transplant recipients. This approach aims to improve patient care by identifying those at higher risk for heart disease early on.
Why it matters
Potential benefit: If successful, this research could lead to better prevention strategies and improved health outcomes for kidney transplant patients at risk of cardiovascular disease.
How similar studies have gone: Previous research has shown promise in using health records for predicting health outcomes, but this specific approach for kidney transplant patients is novel.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Bowring, Mary Grace — Johns Hopkins University
- Study coordinator: Bowring, Mary Grace
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Food allergy antibodies linked to heart disease risk in adults
Many adults have antibodies to foods without symptoms, and this study asks whether those antibodies are linked to higher risk of heart disease and related conditions.
-
Strategies for HIV-to-HIV kidney transplants to increase organ donations
This project looks at making HIV-to-HIV kidney transplantation more common to help people with HIV get transplants faster by boosting organ donation and changing practice.
-
Mindfulness training to lower cardiovascular risk for moms and babies during pregnancy
A mindfulness program is being tested during pregnancy to help prevent high blood pressure and heart problems for mothers and their babies.
-
Integrating clinical pharmacists into HIV care to reduce cardiovascular disease in people with HIV
A pharmacist-led program in HIV care aims to prevent and manage heart disease risks like high blood pressure, diabetes, and high cholesterol in people living with HIV.
-
Biomarker-guided Immunosuppression in Kidney Transplant Patients
A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.